Novartis said FDA has accepted the company's Biologics License Application filing and granted priority review for CTL019 (tisagenlecleucel-T), an investigational chimeric antigen receptor T cell therapy, in relapsed and refractory pediatric and young adult patients with B-cell acute lymphoblastic leukemia.
BMS and Foundation Medicine announced a collaboration that leverages Foundation Medicine's comprehensive genomic profiling and molecular information solutions to identify predictive biomarkers such as Tumor Mutational Burden and Microsatellite Instability in patients enrolled across clinical trials investigating Bristol-Myers Squibb's cancer immunotherapies.
AbbVie and M2Gen said AbbVie has joined the Oncology Research Information Exchange Network Avatar Research Program.
Carlo Croce will receive the 11th Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research during the AACR Annual Meeting 2017, to be held April 1-5, in Washington.
Roger Lo will receive the first AACR-Waun Ki Hong Award for Outstanding Achievement in Cancer Research during the AACR annual meeting.
Fred Hutchinson Cancer Research Center received a $35 million donation from the Bezos family, the largest private contribution in the center's 41-year history.
Special section on survival finds significant improvement for all but two cancer sites March 31, 2017—Overall cancer death rates continue to decrease in men, women, and children for all major racial and ethnic groups, according to the latest Annual Report to the Nation on the Status of Cancer, 1975-2014.
The National Comprehensive Cancer Network launched the NCCN Radiation Therapy Compendium during the NCCN 22nd Annual Conference. The conference was titled “Improving the Quality, Effectiveness, and Efficiency of Cancer Care.”
Kemi DollSaad KenderianFlorian MullerElizabeth StewartThe NCCN Foundation has awarded grants to four young investigators from NCCN member institutions. The grants will provide $150,000 in funding over a two-year period to each awardee, beginning in July 2017.
Friends of Cancer Research launched an online learning community, ProgressForPatients.org. The site is home to two new programs Friends has been developing over the course of the last year, Friends' Advocacy Education and Advocacy Alliance.
